SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-033511
Filing Date
2013-06-07
Accepted
2013-06-07 14:30:24
Documents
1
Period of Report
2013-06-05

Document Format Files

Seq Description Document Type Size
1 rrd381873.html 4  
1 rrd381873.xml 4 9487
  Complete submission text file 0001181431-13-033511.txt   12032
Mailing Address 1119 ST PAUL STREET BALTIMORE MD 21202
Business Address 1119 ST PAUL STREET BALTIMORE MD 21202 410-244-0115
NEW ENTERPRISE ASSOCIATES 13 LP (Reporting) CIK: 0001452907 (see all company filings)

State of Incorp.: E9
Type: 4 | Act: 34 | File No.: 001-35945 | Film No.: 13900253

Mailing Address 1119 ST. PAUL STREET BALTIMORE MD 21202
Business Address 1119 ST. PAUL STREET BALTIMORE MD 21202 410-244-0115
NEA 13 GP, Ltd (Reporting) CIK: 0001460751 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-35945 | Film No.: 13900251

Mailing Address 1119 ST. PAUL STREET BALTIMORE MD 21202
Business Address 1119 ST. PAUL STREET BALTIMORE MD 21202 410-244-0115
NEA Partners 13, Limited Partnership (Reporting) CIK: 0001460752 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-35945 | Film No.: 13900252

Mailing Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139 617-229-5872
Epizyme, Inc. (Issuer) CIK: 0001571498 (see all company filings)

IRS No.: 261349956 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations